Condition: Coronary Artery Disease · Atherosclerosis of Coronary Artery · Myocardial Ischemia · Sponsor: Biotronik AG
The study objective is the assessment of safety and clinical performance of Freesolve 35- and 40-mm in de novo coronary artery lesions up to 38 mm length.
This description comes directly from the study's public registry record.
Barbara Widmann, PhD · 0041 75 429 5530 · barbara.widmann@teleflex.com
Always discuss trial participation with your own doctor first.
| Katholisches Krankenhaus "St. Johann Nepomuk" | Erfurt, Germany | Recruiting |
| Universitätsklinikum Halle (Saale) | Halle, Germany | Recruiting |
| Klinikverbund Allgäu gGmbH | Immenstadt and Kempten, Germany | Recruiting |
| Klinikum der Ludwig-Maximilians-Universität München | München, Germany | Recruiting |
| Semmelweis University | Budapest, Hungary | Recruiting |
| Centro Cardiologico Monzino SpA | Milan, Italy | Recruiting |
| Azienda Ospedaliera Universitaria Integrata Verona | Verona, Italy | Recruiting |
| Pauls Stradins Clinical University Hospital | Riga, Latvia | Recruiting |
| Miedziowe Centrum Zdrowia S.A | Lubin, Poland | Recruiting |
| Hospital Clinic de Barcelona | Barcelona, Spain | Recruiting |
| Hospital de la Princesa | Madrid, Spain | Recruiting |
| Hospital Clinic Universitario de Valladolid | Valladolid, Spain | Recruiting |
+ 2 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07091682